These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6990932)

  • 1. Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis.
    Williams HJ; Reading JC; Ward JR; O'Brien WM
    Arthritis Rheum; 1980 May; 23(5):521-7. PubMed ID: 6990932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.
    Currey HL; Harris J; Mason RM; Woodland J; Beveridge T; Roberts CJ; Vere DW; Dixon AS; Davies J; Owen-Smith B
    Br Med J; 1974 Sep; 3(5934):763-6. PubMed ID: 4606370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide therapy for rheumatoid arthritis.
    Smyth CJ; Bartholomew BA; Mills DM; Steigerwald JC; Strong SJ; Recart S
    Arch Intern Med; 1975 Jun; 135(6):789-93. PubMed ID: 1093503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of cyclophosphamide in rheumatoid arthritis.
    Cooperating Clinics Committee of the American Rheumatism Association
    N Engl J Med; 1970 Oct; 283(17):883-9. PubMed ID: 4917724
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind study of cyclophosphamide in rheumatoid arthritis.
    Lidsky MD; Sharp JT; Billings S
    Arthritis Rheum; 1973; 16(2):148-53. PubMed ID: 4577392
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled trial of cyclophosphamide in rheumatoid arthritis.
    Townes AS; Sowa JM; Shulman LE
    Arthritis Rheum; 1976; 19(3):563-73. PubMed ID: 779796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine and cyclophosphamide as slow-acting drugs for rheumatoid arthritis.
    Decker JL
    Am J Med; 1983 Dec; 75(6A):74-8. PubMed ID: 6660242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic agents in the treatment of rheumatoid arthritis.
    Davis JD; Muss HB; Turner RA
    South Med J; 1978 Jan; 71(1):58-64. PubMed ID: 341332
    [No Abstract]   [Full Text] [Related]  

  • 9. Cooperating clinics committee. Cyclophosphamide therapy of rheumatoid arthritis.
    Fosdick WH
    Arthritis Rheum; 1971; 14(3):363-4. PubMed ID: 4998029
    [No Abstract]   [Full Text] [Related]  

  • 10. A surviving patient after a cumulative dose of 250 g of cyclophosphamide.
    Mercan R; Bitik B; Ekinci Ö; Goker B
    Scand J Rheumatol; 2015; 44(6):520-1. PubMed ID: 26291486
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclophosphamide in severe rheumatoid polyarthritis. Results from a preliminary trial on 10 cases].
    Auquier L; Henrard JC; Siaud JR
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):775-9. PubMed ID: 5152710
    [No Abstract]   [Full Text] [Related]  

  • 12. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.
    Edwards JC; Szczepanski L; Szechinski J; Filipowicz-Sosnowska A; Emery P; Close DR; Stevens RM; Shaw T
    N Engl J Med; 2004 Jun; 350(25):2572-81. PubMed ID: 15201414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
    Williams HJ; Willkens RF; Samuelson CO; Alarcón GS; Guttadauria M; Yarboro C; Polisson RP; Weiner SR; Luggen ME; Billingsley LM
    Arthritis Rheum; 1985 Jul; 28(7):721-30. PubMed ID: 3893441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective pilot study of intravenous pulse cyclophosphamide therapy for refractory rheumatoid arthritis.
    Arnold MH; Janssen B; Schrieber L; Brooks PM
    Arthritis Rheum; 1989 Jul; 32(7):933-4. PubMed ID: 2751725
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate.
    Walters MT; Cawley MI
    Ann Rheum Dis; 1988 Nov; 47(11):924-9. PubMed ID: 3144941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.
    Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F
    Arthritis Rheum; 1990 Mar; 33(3):330-8. PubMed ID: 2180405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens.
    Pavelka K; Sen KP; Pelísková Z; Vácha J; Trnavský K
    Ann Rheum Dis; 1989 Jul; 48(7):542-6. PubMed ID: 2673079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late hemorrhagic cystitis following low-dose cyclophosphamide therapy.
    Marshall FF; Klinefelter HF
    Urology; 1979 Dec; 14(6):573-5. PubMed ID: 516210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.